SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-016116
Filing Date
2024-05-13
Accepted
2024-05-13 08:05:30
Documents
88
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q urgn20240331_10q.htm   iXBRL 10-Q 1563954
2 EXHIBIT 10.1 ex_669308.htm EX-10.1 11918
3 EXHIBIT 10.2 ex_669309.htm EX-10.2 54195
4 EXHIBIT 31.1 ex_649855.htm EX-31.1 17123
5 EXHIBIT 31.2 ex_649856.htm EX-31.2 17108
6 EXHIBIT 32.1 ex_649857.htm EX-32.1 6487
7 EXHIBIT 32.2 ex_649858.htm EX-32.2 6472
  Complete submission text file 0001437749-24-016116.txt   6737362

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA urgn-20240331.xsd EX-101.SCH 68375
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE urgn-20240331_cal.xml EX-101.CAL 45999
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE urgn-20240331_def.xml EX-101.DEF 383699
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE urgn-20240331_lab.xml EX-101.LAB 336566
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urgn-20240331_pre.xml EX-101.PRE 422942
92 EXTRACTED XBRL INSTANCE DOCUMENT urgn20240331_10q_htm.xml XML 881143
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38079 | Film No.: 24936961
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)